We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

Fund managers haven’t disclosed any holdings of DTIL yet.

DTIL Hedge Fund Activity: Q1 2026 in Review

78 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2026, worth a combined $88.1M — up 40% from $62.8M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DTIL positions and 11 closed out — a net gain of 10 holders — while 24 added to existing stakes and 13 trimmed.

The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $2.76M. The largest seller was Alyeska Investment Group, cutting an estimated $3.04M.

  • 78 institutional investors held Precision BioSciences (DTIL) as of Q1 2026, up from 69 in Q4 2025.
  • Funds reported $88.1M of Precision BioSciences stock for Q1 2026, up 40% quarter-over-quarter.
  • 21 funds opened new Precision BioSciences positions in Q1 2026 and 11 closed out, a net change of +10 holders.
  • The largest Precision BioSciences buyer in Q1 2026 was Affinity Asset Advisors, an estimated $2.76M added.
  • The largest Precision BioSciences seller in Q1 2026 was Alyeska Investment Group, an estimated $3.04M sold.

Based on aggregated 13F filings for Q1 2026.